#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuropathic arthropathy Superficial vein thrombosis Stiff person syndrome Cardiac arrest Blood iron increased Renal cell carcinoma Becker's muscular dystrophy Spinal cord injury Primary immunodeficiency syndrome Uveal melanoma Fms-like tyrosine kinase 3 positive Cervix carcinoma recurrent Vascular calcification X-linked lymphoproliferative syndrome Prodromal Alzheimer's disease More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Diagnostics Ewing’s sarcoma – Treatment Rosai-Dorfman syndrome Glomerulonephritis membranoproliferative – Treatment Krabbe’s disease – Trials in Disease Choroid melanoma – Life with Disease Osteosarcoma Mucopolysaccharidosis III – Trials in Disease Cystic fibrosis lung Pleural mesothelioma malignant – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenazone Oxcarbazepine Specific Nucleic Acid Sna-Xfsb Motixafortide Mirodenafil Dihydrochloride Amoxicillin Sodium Lacosamide Ethambutol Hydrochloride Crinecerfont Belantamab Mafodotin ATIGOTATUG IDOR-1117-2520C Fluorodopa (18F) Fadraciclib Vedolizumab Bi 3032950 Roginolisib Sertraline Hydrochloride Sodium Gluconate Mirabegron More therapies…

    Learn about Your Condition

    Endocarditis Aortic valve stenosis Henoch-Schonlein purpura Myocarditis post infection Neonatal asphyxia Oesophageal atresia Cardiac failure chronic B-cell lymphoma refractory Haemorrhage prophylaxis Carpal tunnel syndrome Encephalitis Japanese B Ocular hypertension Intestinal infarction Bone marrow disorder Tachypnoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Cilastatin
    • Imipenem Anhydrate
    • Tebipenem Pivoxil Hydrobromide
    Bulgaria Croatia Estonia Greece Hungary Latvia +3

  • Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Czechia Denmark Greece Hungary Italy Poland +1

  • Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Primary myelofibrosis
    Investigated Drugs:
    • Luspatercept
    • Sodium Chloride
    Austria Belgium Czechia France Germany Greece +6

  • Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

    Not recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Imatinib
    Austria Belgium Czechia France Germany Greece +8

  • Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Aficamten
    Denmark France Germany Greece Hungary Iceland +5

  • Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombotic microangiopathy
    Investigated Drugs:
    • Ravulizumab
    Belgium France Germany Greece Italy The Netherlands +3

  • Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Imatinib
    Austria Belgium Czechia France Germany Greece +8

  • Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    France Germany Greece Ireland Italy Poland +1

  • Study on Anti-COVID-19 Hyperimmune Globulin for Treating Adults with Early COVID-19 Symptoms

    Not recruiting

    3 1
    Investigated Drugs:
    • Anti-Sars-Cov-2 Polyclonal Hyperimmune Globulin
    Denmark Greece Spain

  • Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epcoritamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia Denmark +10
Previous Page
1 … 8 9 10 11 12 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!